Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Hold QinetiQ Group (QQ.) by Shore Capital
- Avoid Eagle Eye Solutions Group (EYE) by Steve Moore in ShareProphets
- Outperform Domino's Pizza Group (DOM) by RBC Capital
- Avoid Marshalls (MSLH) by Steve Moore in ShareProphets
- Hold SIG (SHI) by Deutsche Bank
- Sell Bakkavor Group (BAKK) by Tom Winnifrith in ShareProphets
- Sell Bakkavor Group (BAKK) by Steve Moore in ShareProphets
- Buy Phoenix Group Holdings (PHNX) by Bank of America
- Buy Deliveroo Class (ROO) by Bank of America
- Watch Beeks Financial Cloud Group (BKS) by Steve Moore in ShareProphets
- Sell Hemogenyx Pharmaceuticals (HEMO) by Tom Winnifrith in ShareProphets
- Sell Predator Oil & Gas Holdings NPV (PRD) by Tom Winnifrith in ShareProphets
- Hold Glencore (GLEN) by Simon Watkins in The Motley Fool
- Overweight Sabre Insurance Group (SBRE) by Barclays
- Add Legal & General Group (LGEN) by Simon Watkins in The Motley Fool
- Buy DFS Furniture (DFS) by Jefferies
- Sell Phoenix Group Holdings (PHNX) by Goldman Sachs
- Buy Deliveroo Class (ROO) by Bryan Garnier
- Buy JD Sports Fashion (JD.) by James Beard in The Motley Fool
- Hold Care Reit (CRT) by Russ Mould in The Telegraph - Questor
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,202 open tips for AstraZeneca (AZN)
| Latest Bid : 11,872.00p | Latest Ask : 11,876.00p |
| High Today : 11,978.00p | Low Today : 11,810.00p |
| This Years High : 13,276.00p | This Years Low : 9,725.00p |
| Volume : 567,150 | MKT Cap : £183613M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Outperform | ODDO BHF | Premium Only | 2025-03-14 09:58:00 14/03/2025 | -0.75% |
| Buy | Shore Capital | Premium Only | 2025-03-07 08:11:00 07/03/2025 | -0.94% |
| Overweight | JP Morgan | Premium Only | 2025-02-19 15:02:00 19/02/2025 | 0.83% |
| Buy | LBBW | Premium Only | 2025-02-14 10:17:00 14/02/2025 | 0.17% |
| Buy | UBS | Premium Only | 2025-02-13 05:29:00 13/02/2025 | -1.30% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 11,872.00p | Latest Ask : 11,876.00p |
| High Today : 11,978.00p | Low Today : 11,810.00p |
| This Years High : 13,276.00p | This Years Low : 9,725.00p |
| Volume : 567,150 | MKT Cap : £183613M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Outperform | ODDO BHF | Premium Only | 2025-03-14 09:58:00 14/03/2025 | -0.75% |
| Buy | Shore Capital | Premium Only | 2025-03-07 08:11:00 07/03/2025 | -0.94% |
| Overweight | JP Morgan | Premium Only | 2025-02-19 15:02:00 19/02/2025 | 0.83% |
| Buy | LBBW | Premium Only | 2025-02-14 10:17:00 14/02/2025 | 0.17% |
| Buy | UBS | Premium Only | 2025-02-13 05:29:00 13/02/2025 | -1.30% |